nebilet plus h 5mg/12,5mg potahovaná tableta
menarini international operations luxembourg s.a., luxembourg array - 12056 nebivolol-hydrochlorid; 728 hydrochlorothiazid - potahovaná tableta - 5mg/12,5mg - nebivolol a thiazidy
nebilet plus h 5mg/25mg potahovaná tableta
menarini international operations luxembourg s.a., luxembourg array - 12056 nebivolol-hydrochlorid; 728 hydrochlorothiazid - potahovaná tableta - 5mg/25mg - nebivolol a thiazidy
neurotop retard 300mg tableta s prodlouženým uvolňováním
g.l. pharma gmbh, lannach array - 1676 karbamazepin - tableta s prodlouženým uvolňováním - 300mg - karbamazepin
neurotop retard 600mg tableta s prodlouženým uvolňováním
g.l. pharma gmbh, lannach array - 1676 karbamazepin - tableta s prodlouženým uvolňováním - 600mg - karbamazepin
topiramate neuraxpharm 100mg potahovaná tableta
neuraxpharm bohemia s.r.o., praha ČeskÁ republika - 10722 topiramÁt - potahovaná tableta - 100mg - topiramÁt
topiramate neuraxpharm 200mg potahovaná tableta
neuraxpharm bohemia s.r.o., praha ČeskÁ republika - 10722 topiramÁt - potahovaná tableta - 200mg - topiramÁt
topiramate neuraxpharm 50mg potahovaná tableta
neuraxpharm bohemia s.r.o., praha ČeskÁ republika - 10722 topiramÁt - potahovaná tableta - 50mg - topiramÁt
bevimlar 10mg potahovaná tableta
stada arzneimittel ag, bad vilbel array - 17116 rivaroxaban - potahovaná tableta - 10mg - rivaroxaban
bevimlar 15mg+20mg potahovaná tableta
stada arzneimittel ag, bad vilbel array - 17116 rivaroxaban; 17116 rivaroxaban - potahovaná tableta - 15mg+20mg - rivaroxaban
clopidogrel acino
acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotické činidla - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.